Trials / Conditions / EGFR Overexpression
EGFR Overexpression
4 registered clinical trials studyying EGFR Overexpression — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors NCT06975410 | Yuhan Corporation | Phase 1 / Phase 2 |
| Recruiting | HER-2 B Cell Peptide Vaccine NCT06414733 | Pravin T.P Kaumaya | Phase 1 |
| Active Not Recruiting | A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characte NCT06309043 | Shanghai Henlius Biotech | Phase 1 |
| Unknown | TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors NCT04976218 | Chinese PLA General Hospital | Phase 1 |